Otitis media with effusion-effusion study
Completed
- Conditions
- otitis media with effusion / glue-ear10027584
- Registration Number
- NL-OMON35421
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 15
Inclusion Criteria
otitis media with effusion
Exclusion Criteria
cleft palate
Down syndrome
immunological disorders
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p> Analysis of middle ear effusion for mediators of inflammation and factors of<br /><br>gastro-oesophageal reflux.<br /><br></p><br>
- Secondary Outcome Measures
Name Time Method <p>NA</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie otitis media with effusion in pediatric patients enrolled in NL-OMON35421?
How does the observational design of NL-OMON35421 compare to randomized controlled trials for glue ear management?
Are there specific biomarkers identified in the OME-effusion study that correlate with resolution of middle ear effusion?
What are the potential long-term adverse events associated with non-invasive monitoring approaches in otitis media with effusion studies?
How do current observational studies like NL-OMON35421 inform the development of novel therapies for persistent otitis media with effusion?